scispace - formally typeset
Search or ask a question

Showing papers on "Nucleic acid methods published in 1988"


Patent
01 Jul 1988
TL;DR: Pyridinone or pyrimidine nucleoside bases containing fused aromatic polycyclic rings are provided in this paper, which can be used as improved probes, diagnostic reagents, or for cleaving or derivatizing predetermined domains within nucleic acids.
Abstract: Pyridinone or pyrimidinone nucleoside bases containing fused aromatic polycyclic rings are provided. These polycyclic nucleosides are incorporated into oligonucleotides and hybridized to complementary nucleic acid. Fluorescence spectroscopy and thermal denaturation profiles provided evidence that the polycyclic base is intercalated into the resulting duplex. The fused polycyclic ring systems optionally are substituted with reactive species which inactivate complementary nucleic acids. The oligonucleotides of this invention are useful as improved probes, diagnostic reagents, or for cleaving or derivatizing predetermined domains within nucleic acids.

543 citations


Patent
17 Oct 1988
TL;DR: Linear or branched oligonucleotide multimers are useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonotide unit that is complementary to a singlestranded sequence of interest, and (2) a multiplicity of second single strand-linked oligon nucleotide units that are complementary to the label of interest as mentioned in this paper.
Abstract: Linear or branched oligonucleotide multimers useful as amplifiers in biochemical assays which comprise (1) at least one first single-stranded oligonucleotide unit that is complementary to a single-stranded oligonucleotide sequence of interest, and (2) a multiplicity of second single-stranded oligonucleotide units that are complementary to a single-stranded labeled oligonucleotide. Amplified sandwich nucleic acid hybridizations and immunoassays using the multimers are exemplified.

521 citations


Patent
17 Jun 1988
TL;DR: In this paper, the novelty of certain RNA transcripts, their production, optional replication, and use, to achieve desired amplification and detection of corresponding (in sequence) target nucleic acid sequence.
Abstract: The present invention is predicated on the novelty of certain RNA transcripts, their production, optional replication, and use, to achieve desired amplification and detection of corresponding (in sequence) target nucleic acid sequence. The transcripts correspond in sequence to a target nucleic acid sequence contained in an original sample amongst a mixture of nucleic acids, and therefore, the presence of the transcripts in amplified form provides for their detection, and hence by correspondence, the in vitro or x-vivo detection of the presence of the target nucleic acid sequence in said sample.

423 citations


Patent
22 Nov 1988
TL;DR: In this article, a helper oligonucleotides are selected to bind to the target nucleic acid and impose a different secondary and tertiary structure on the target to facilitate the binding of the probe to a target.
Abstract: The binding of a nucleic acid probe with its complementary sequence in a targeted, single stranded nucleic acid is affected by the secondary and tertiary structure of the target nucleic acid. The rate and extent of hybridization of the probe with the targeted nucleic acid can be increased by the use of "helper" oligonucleotides. Helper oligonucleotides are selected to bind to the target nucleic acid and impose a different secondary and tertiary structure on the target to facilitate the binding of the probe to the target. The resulting hybrid of probe and target nucleic acid also exhibits a higher T m than the hybrid which results from addition of the probe alone.

180 citations


Patent
02 Mar 1988
TL;DR: In this article, the use of polycationic solid supports in the purification of nucleic acids from solutions containing contaminants is described, where nucleic acid non-covalently bind to the support without significant binding of contaminants permitting their separation from the contaminants.
Abstract: Described herein is the use of polycationic solid supports in the purification of nucleic acids from solutions containing contaminants. The nucleic acids non-covalently bind to the support without significant binding of contaminants permitting their separation from the contaminants. The bound nucleic acids can be recovered from the support. Also described is the use of the supports as a means to separate polynucleotides and hybrids thereof with a nucleotide probe from unhybridized probe. Assays for target nucleotide sequences are described which employ this separation procedure.

156 citations


Patent
03 Mar 1988
TL;DR: In this article, a method for detecting one or more microorganisms or nucleic acid sequences from a prokaryotic source or an eukaryotic sources in a nucleic ��acid-containing test sample comprising labeling the nucleic acids in the test ��sample, contacting, under hybridization ��conditions, the labeled hybridizable nucleic acyclic acid and one ��or more immobilized hybridizable NCA probes, to form ��hybridized labeled NCA, and assaying for the hybridized NCA.
Abstract: A method for detecting (i) one or more microorganisms or (ii) nucleic acid sequences from a prokaryotic source or an eukaryotic source in a nucleic acid-containing test sample comprising (a) labeling the nucleic acids in the test sample, (b) contacting, under hybridization conditions, the labeled hybridizable nucleic acid and one or more immobilized hybridizable nucleic acid probes comprising (i) one or more known microorganisms or (ii) sequences from eukaroytic or prokaryotic sources, to form hybridized labeled nucleic acids, and (d) assaying for the hybridized nucleic acids by detecting the label. The method can be used to detect genetic disorders, e.g., sickle-cell anemia.

65 citations


Book ChapterDOI
CJ Brady1
01 Jan 1988

50 citations


Patent
28 Jul 1988
TL;DR: In this paper, the authors proposed a set of DNA probes for the detection of human papilloma for each of the types HPV1a, HPV5, HPV8, HPV11, HPV16, HPV18 and HPV33.
Abstract: The present invention relates to probes of nucleic acids useful for detecting indifferently the various types of human papilloma virus, particularly HPV1a, HPV5, HPV6b, HPV8, HPV11, HPV16, HPV18 and HPV33, especially a probe comprising a labelled sequence of nucleic acids, characterized in that it comprises the oligomer of twelve nucleotides X-A-A-A-A-C-G-A-A-A-G-X, with X=T or U, or its complement by interchanging A and X on the one hand, C and G on the other hand. The present invention also relates to specific probes of nucleic acids for the detection of human papilloma for each of the types HPV1a, HPV5, HPV8, HPV11, HPV16, HPV18 and HPV33, as well as specific probes of sub-groups of the virus HPV16, HPV18, HPV33 or HPV16 and HPV18 only or again HPV5 and HPV8 only.

43 citations


Patent
09 Dec 1988
TL;DR: In order to sequence nucleic acids, one produces a mixture of labelled nucleic acid fragments of different length, using nuclei acid fragments which are labelled by incorporation of at least one deoxyribonucleoside triphosphate with a non-radioactive labelling group, separating the labelled nucleis acid fragments according to size and determining the nucleic amino acid sequence by means of the labelling of the individual fragments as mentioned in this paper.
Abstract: In order to sequence nucleic acids one produces a mixture of labelled nucleic acid fragments of different length, using nucleic acid fragments which are labelled by incorporation of at least one deoxyribonucleoside triphosphate with a non-radioactive labelling group, separates the labelled nucleic acid fragments according to size and determines the nucleic acid sequence by means of the labelling of the individual fragments.

43 citations


Patent
01 Apr 1988
TL;DR: In this paper, a process for the isolation of nucleic acids from cell or tissue extracts by precipitating the nucleic acid with a water-soluble ketone, preferably with acetone, optionally in the presence of dimethylformamide or formamide is described.
Abstract: A process for the isolation of nucleic acids from cell or tissue extracts by precipitating the nucleic acids with a water-soluble ketone, preferably with acetone, optionally in the presence of dimethylformamide or formamide.

27 citations


Patent
23 Nov 1988
TL;DR: In this article, a multi-step process involving labeling sample nucleic acid sequences, duplexing the labeled sample with a probe having a coupling element, immobilizing all of the duplexed probe and target sequence and unduplexing probe, separating specifically immobilized nucleic acids from free and non-specifically immobilized ones, and detecting the presence of the sequence of interest by means of the label.
Abstract: Nucleic acid sequences are detected by a multi-step process, involving labeling sample nucleic acid sequences, duplexing the labeled sample with a probe having a coupling element, immobilizing all of the duplexed probe and target sequence and unduplexed probe, separating specifically immobilized nucleic acid from free and non-specifically immobilized nucleic acid, releasing specifically immobilized nucleic acid, and detecting the presence of the sequence of interest by means of the label. The labeled sequence may be characterized by sizing, e.g. electrophoresis. The method provides for a sensitive and rapid means for accurate detection of sequences of interest in a wide variety of situations.

Patent
23 Dec 1988
TL;DR: In this paper, a method for detecting a target nucleic acid in a specimen, which comprises hybridizing in a sample a primer of at least one strand of the nuclei acid chains of a target NCA and adding a unit nucleic acids thereto for elongation of the chain to thereby prepare a synthetic NCA complementary to and hybridized with said strand, is presented.
Abstract: A method for detecting a target nucleic acid in a specimen, which comprises hybridizing in a specimen a primer of at least one strand of the nucleic acid chains of a target nucleic acid and adding a unit nucleic acid thereto for elongation of the chain to thereby prepare a synthetic nucleic acid complementary to and hybridized with said strand, thus obtaining a copy of the target nucleic acid comprising (a) the double-stranded nucleic acid thus formed, (b) a synthetic nucleic acid prepared by separating the double-stranded nucleic acid into a single-stranded nucleic acid, or (c) a double-stranded nucleic acid which is a double-stranded hybridized product complementary to the synthetic nucleic acid, and examining whether this copy exists or not in the sample.

Patent
21 Dec 1988
TL;DR: In this article, a multi-step process involving labeling sample nucleic acid sequences, duplexing the labeled sample with a probe having a coupling element, immobilizing all of the duplexed probe and target sequence and unduplexing probe, separating specifically immobilized nucleic acids from free and non-specifically immobilized ones, and detecting the presence of the sequence of interest by means of the label.
Abstract: Nucleic acid sequences are detected by a multi-step process, involving labeling sample nucleic acid sequences, duplexing the labeled sample with a probe having a coupling element, immobilizing all of the duplexed probe and target sequence and unduplexed probe, separating specifically immobilized nucleic acid from free and non-specifically immobilized nucleic acid, releasing specifically immobilized nucleic acid, and detecting the presence of the sequence of interest by means of the label. The labeled sequence may be characterized by sizing, e.g. electrophoresis. The method provide for a sensitive and rapid means for accurate detection of sequence of interest in a wide variety of situations.

Journal ArticleDOI
07 Jul 1988-Nature
TL;DR: The separation capabilities of ion exchange, when coupled with the principles of reversed-phase fractionation, yields an advanced technology for the manipulation of nucleic acids.
Abstract: The separation capabilities of ion exchange, when coupled with the principles of reversed-phase fractionation, yields an advanced technology for the manipulation of nucleic acids.

BookDOI
31 Aug 1988

Patent
29 Jul 1988
TL;DR: A nucleic acid capture reagent is a reagent which comprises one or more molecules that are capable of intercalation into nucleic acids and are attached to a solid support via a molecular linker as discussed by the authors.
Abstract: A nucleic acid capture reagent which comprises one or more molecules that are capable of intercalation into nucleic acids and are attached to a solid support via a molecular linker. This capture reagent is useful for the separation and isolation of nucleic acids from complex unpurified biological solutions such as serum, sputum, blood, and urine. The resulting capture reagent-nucleic acid complexes are easily isolated from the sample solution by mechanical or magnetic means and the bound nucleic acids are released by simple chemical treatment.

Patent
06 Apr 1988
TL;DR: In this article, the bestimmenden Nucleinsauresequenzen in Einzelstrange and Umsetzung with einer komplementaren poly nucleotidsonde are found.
Abstract: Die Erfindung betrifft Verfahren und Mittel zur Bestimmung von Nucleinsauren in einer Probe durch Uberfuhrung der zu bestimmenden Nucleinsauresequenzen in Einzelstrange und Umsetzung der Einzelstrange mit einer komplementaren Poly nucleotidsonde. In der Polynucleotidsonde ist Cytidin durch 5-Aza-2′-desoxy-cytidin oder 5-Aza-cytidin ersetzt. Die Sonde wird nach Bindung mit gegebenenfalls markierter DNA-Methylase und Nachweise der Methylase uber spezifische, gegebenenfalls markierte anti-Methylase-Antikorper oder uber den Marker bestimmt.

Journal ArticleDOI
TL;DR: A non-swellable, highly porous support material -CPG 3000 - was used in building up covalently bound nucleic acids by combined chemical and enzymatic methods, finding bases are optimal accessible for hybridization and enzyme reactions because they are not involved in the linking procedure.
Abstract: A non-swellable, highly porous support material -CPG 3000 - was used in building up covalently bound nucleic acids by combined chemical and enzymatic methods. Bases are optimal accessible for hybridization and enzymatic reactions because they are not involved in the linking procedure.


Patent
18 Mar 1988
TL;DR: A method for detecting point mutations in the highest melting domain (HMD) of a double-stranded nucleic acid polymer was proposed in this article, which is particularly suited for use with RNA.
Abstract: A method for detecting point mutations or base substitutions in a nucleic acid polymer is especially useful for detecting such mutations in the highest melting domain (HMD) of a double-stranded nucleic acid polymer and is particularly suited for use with RNA. The method involves the steps of: (a) preparing a solution containing a double-stranded nucleic acid polymer comprising a duplex of a single-stranded nucleic acid polymer to be analyzed and a c The invention described and claimed in this application was made with government support under Grant #DK-38381 awarded by the National Institutes of Health. The U.S. government has certain rights in the invention.


Patent
15 Apr 1988
TL;DR: In this paper, the nucleic acids are precipitated with water-soluble ketone, preferably with acetone, if appropriate in the presence of dimethylformamide or formamide.
Abstract: Process for the isolation of nucleic acids from cell or tissue extracts, characterised in that the nucleic acids are precipitated with water-soluble ketone, preferably with acetone, if appropriate in the presence of dimethylformamide or formamide.

Patent
16 Sep 1988
TL;DR: In this article, a primer complimentary to a nucleic acid sequence is subjected to an elongation reaction and the resultant nucleic amino acid sequence, or other nucleic acids sequence part having two-chains formed with individual elongated primer substances are detected after fixed to a solid phase carrier.
Abstract: PURPOSE: To make possible to readily detect in high sensitivity, by subjecting a primer complimentary to a nucleic acid sequence to be detected to an elongation reaction, fixing the nucleic acid sequence of resultant elongated substance and detecting. CONSTITUTION: At least one primer complimentary to a nucleic acid sequence to be detected is used. The primer complimentary to the nucleic acid sequence is subjected to elongation reaction and the resultant nucleic acid sequence, or other nucleic acid sequence part having two-chains formed with individual elongated primer substances are detected after fixed to a solid phase carrier. COPYRIGHT: (C)1989,JPO&Japio



Patent
11 Mar 1988
TL;DR: In this article, the authors proposed a method for detecting one or more microorganisms or nucleic acid sequences from a prokaryotic source or an eukaryotic sources in a test sample.
Abstract: A method for detecting (i) one or more microorganisms or (ii) nucleic acid sequences from a prokaryotic source or an eukaryotic source in a nucleic acid-containing test sample comprising (a) labeling the nucleic acids in the test sample, (b) contacting, under hybridization conditions, the labeled hybridizable nucleic acid and one or more immobilized hybridizable nucleic acid probes comprising (i) one or more known microorganisms or (ii) sequences from eukaroytic or prokaryotic sources, to form hybridized labeled nucleic acids, and (d) assaying for the hybridized nucleic acids by detecting the label. The method can be used to detect genetic disorders, e.g., sickle-cell anemia. o

Patent
06 Oct 1988
TL;DR: In this article, a nucleic acid hybridization method was proposed for identifying a specific DNA sequence, especially from a microorganism in a culture thereof, by using volumes of about 5-30 microliters of a highly concentrated probe reagent, the low volumes being applied to a limited area of about 2-5 millimeters comprising an isolated nucleic acids binding surface.
Abstract: The present method provides a nucleic acid hybridization method for identifying a specific nucleic acid sequence, especially from a microorganism in a culture thereof. The method utilizes volumes of about 5-30 microliters of a highly concentrated nucleic acid probe reagent, the low volumes being applied to a limited area of about 2-5 millimeters comprising an isolated nucleic acid binding surface.

Patent
02 Mar 1988
TL;DR: Assays for target nucleotide sequences are described which employ the use of polycationic solid supports as a means to separate polynucleotides and hybrids thereof with a nucleotide probe from unhybridized probe.
Abstract: @ Described herein is the use of polycationic solid supports in the purification of nucleic acids from solutions containing contaminants. The nucleic acids non-covalently bind to the support without signficant binding of contaminants permitting their separation from the contaminants. The bound nucleic acids can be recovered from the support. Also described is the use of the supports as a means to separate polynucleotides and hybrids thereof with a nucleotide probe from unhybridized probe. Assays for target nucleotide sequences are described which employ this separation procedure. o